Submitted:
18 June 2024
Posted:
18 June 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Participants
2.3. Questionnaires and Educational Interventions
2.4. Study Sample and Statistical Analysis
3. Results
4. Discussion
4.1. The Impact and Role of Educational Interventions in Addressing Public Health Issues among Populations with Disproportionate Outcomes
4.2. Factors Influencing COVID-19 Attitudes and Knowledge: Gender, Political Affiliation, Place of Residence, Number of CDC Precautions Followed, and Number of Co-Morbidities
4.2.1. Gender
4.2.2. Political Affiliation
4.2.3. Place of Residence
4.2.4. Number of CDC Precautions Followed
4.2.5. Number of Co-Morbidities
4.3. Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
| 1 | Mean values that show a value closer to 0 indicate an incorrect response, 1 indicates a partially correct response, and 2 indicates a completely correct response. |
| 2 | Mean values that show a value closer to 0 indicate “disagree” and 2 indicates “agree”. |
| 3 | The “Unvaccinated, hesitated” individuals include those who selected “Definitely will not,” “Very unlikely,” and “Somewhat unlikely” to the question, “If given the opportunity to take a COVID-19 vaccine, how likely is it that you would get the vaccine/shot?” |
| 4 | The “Unvaccinated, not hesitant” individuals include those who selected “Somewhat likely,” “Very likely,” and, “Definitely will”; the “vaccinated” individuals include those who received one or more COVID-19 vaccinations. |
References
- C. Grills et al., “Applying culturalist methodologies to discern COVID-19’s impact on communities of color,” (in eng), J Community Psychol, vol. 51, no. 6, pp. 2331-2354, Jul 2023. [CrossRef]
- M. Y. Brave Heart et al., “Psychiatric disorders and mental health treatment in American Indians and Alaska Natives: results of the National Epidemiologic Survey on Alcohol and Related Conditions,” (in eng), Soc Psychiatry Psychiatr Epidemiol, vol. 51, no. 7, pp. 1033-46, Jul 2016. [CrossRef]
- M. L. Castor, M. S. Smyser, M. M. Taualii, A. N. Park, S. A. Lawson, and R. A. Forquera, “A nationwide population-based study identifying health disparities between American Indians/Alaska Natives and the general populations living in select urban counties,” (in eng), Am J Public Health, vol. 96, no. 8, pp. 1478-84, Aug 2006. [CrossRef]
- S. M. Manson, J. Beals, S. A. Klein, C. D. Croy, and A.-S. Team, “Social epidemiology of trauma among 2 American Indian reservation populations,” (in eng), Am J Public Health, vol. 95, no. 5, pp. 851-9, May 2005. [CrossRef]
- C. A. Wong et al., “American Indian and Alaska Native infant and pediatric mortality, United States, 1999-2009,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S320-8, Jun 2014. [CrossRef]
- M. A. Herne, M. L. Bartholomew, and R. L. Weahkee, “Suicide mortality among American Indians and Alaska Natives, 1999-2009,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S336-42, Jun 2014. [CrossRef]
- M. Landen, J. Roeber, T. Naimi, L. Nielsen, and M. Sewell, “Alcohol-attributable mortality among American Indians and Alaska Natives in the United States, 1999-2009,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S343-9, Jun 2014. [CrossRef]
- M. Veazie, C. Ayala, L. Schieb, S. Dai, J. A. Henderson, and P. Cho, “Trends and disparities in heart disease mortality among American Indians/Alaska Natives, 1990-2009,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S359-67, Jun 2014. [CrossRef]
- T. Murphy, P. Pokhrel, A. Worthington, H. Billie, M. Sewell, and N. Bill, “Unintentional injury mortality among American Indians and Alaska Natives in the United States, 1990-2009,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S470-80, Jun 2014. [CrossRef]
- D. K. Espey et al., “Leading causes of death and all-cause mortality in American Indians and Alaska Natives,” (in eng), Am J Public Health, vol. 104 Suppl 3, no. Suppl 3, pp. S303-11, Jun 2014. [CrossRef]
- D. A. Henderson et al., “Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense,” (in eng), JAMA, vol. 281, no. 22, pp. 2127-37, Jun 09 1999. [CrossRef]
- S. M. Hatcher et al., “COVID-19 Among American Indian and Alaska Native Persons—23 States, January 31-July 3, 2020,” (in eng), MMWR Morb Mortal Wkly Rep, vol. 69, no. 34, pp. 1166-1169, Aug 28 2020. [CrossRef]
- J. Arrazola et al., “COVID-19 Mortality Among American Indian and Alaska Native Persons—14 States, January-June 2020,” (in eng), MMWR Morb Mortal Wkly Rep, vol. 69, no. 49, pp. 1853-1856, Dec 11 2020. [CrossRef]
- D. Allington, B. Duffy, S. Wessely, N. Dhavan, and J. Rubin, “Health-protective behaviour, social media usage and conspiracy belief during the COVID-19 public health emergency,” (in eng), Psychol Med, vol. 51, no. 10, pp. 1763-1769, Jul 2021. [CrossRef]
- J. Khubchandani, S. Sharma, J. H. Price, M. J. Wiblishauser, M. Sharma, and F. J. Webb, “COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment,” (in eng), J Community Health, vol. 46, no. 2, pp. 270-277, 04 2021. [CrossRef]
- M. Clinic, “Herd immunity and COVID-19.
- (coronavirus): What you need to know,” ed, 2021.
- “Michigan Department of Health & Human Services.” https://www.michigan.gov/documents/coronavirus/MI_COVID-19_Vaccination_Prioritization_Guidance_710349_7.pdf. (accessed.
- M. A. Takagi et al., “The impact of educational interventions on COVID-19 and vaccination attitudes among patients in Michigan: A prospective study,” (in eng), Front Public Health, vol. 11, p. 1144659, 2023. [CrossRef]
- C. f. D. C. a. Prevention. US Department of Health and Human Services, CDC. ttps://covid.cdc.gov/covid-data-tracker (accessed April 5, 2021).
- G. Sears et al., “Building Trust and Awareness to Increase AZ Native Nation Participation in COVID-19 Vaccines,” (in eng), Int J Environ Res Public Health, vol. 20, no. 1, Dec 20 2022. [CrossRef]
- R. Treisman. “https://www.npr.org/sections/coronavirus-live-updates/2021/04/26/990884991/outpacing-the-u-s-hard-hit-navajo-nation-has-vaccinated-more-than-half-of-adults.” NPR. https://www.npr.org/sections/coronavirus-live-updates/2021/04/26/990884991/outpacing-the-u-s-hard-hit-navajo-nation-has-vaccinated-more-than-half-of-adults (accessed April 26, 2021).
- U. S. D. o. H. a. H. Services, “Indian Health Service: COVID-19 Pandemic Vaccine Plan November 2020,” ed, 2020.
- H. Kaur. “Tribal health providers have figured out the key to Covid-19 vaccine success. Here’s their secret.” https://www.cnn.com/2021/02/09/us/tribal-health-providers-covid-vaccine-trnd/index.html (accessed February 26, 2021, 2021).
- M. Tutt et al., “Diné teachings and public health students informing peers and relatives about vaccine education: Providing Diné (Navajo)-centered COVID-19 education materials using student health messengers,” (in eng), Front Public Health, vol. 10, p. 1046634, 2022. [CrossRef]
- J. Takeshita et al., “Association of Racial/Ethnic and Gender Concordance Between Patients and Physicians With Patient Experience Ratings,” (in eng), JAMA Netw Open, vol. 3, no. 11, p. e2024583, Nov 02 2020. [CrossRef]
- M. Kahn-John, “The path to development of the Hózhó Resilience Model for nursing research and practice,” (in eng), Appl Nurs Res, vol. 29, pp. 144-7, Feb 2016. [CrossRef]
- M. V. Geana, K. A. Greiner, A. Cully, M. Talawyma, and C. M. Daley, “Improving health promotion to American Indians in the midwest United States: preferred sources of health information and its use for the medical encounter,” (in eng), J Community Health, vol. 37, no. 6, pp. 1253-63, Dec 2012. [CrossRef]
- D. Warne and D. Lajimodiere, “American Indian health disparities: psychosocial influences,” Social and Personality Psychology Compass, vol. 9/10, pp. 567–579, 2015. [CrossRef]
- C. L. Jones, J. D. Jensen, C. L. Scherr, N. R. Brown, K. Christy, and J. Weaver, “The Health Belief Model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation,” (in eng), Health Commun, vol. 30, no. 6, pp. 566-76, 2015. [CrossRef]
- T. D. Noe, C. E. Kaufman, L. J. Kaufmann, E. Brooks, and J. H. Shore, “Providing culturally competent services for American Indian and Alaska Native veterans to reduce health care disparities,” (in eng), Am J Public Health, vol. 104 Suppl 4, no. Suppl 4, pp. S548-54, Sep 2014. [CrossRef]
- S. M. Manson and D. S. Buchwald, “Aging and Health of American Indians and Alaska Natives: Contributions from the Native Investigator Development Program,” (in eng), J Aging Health, vol. 33, no. 7-8_suppl, pp. 3S-9S, 2021. [CrossRef]
- W. F. Denetclaw et al., “Diné Navajo Resilience to the COVID-19 pandemic,” (in eng), PLoS One, vol. 17, no. 8, p. e0272089, 2022. [CrossRef]
- “StatPearls,” 2024.
- M. Santiago-Torres et al., “Efficacy and Utilization of Smartphone Applications for Smoking Cessation Among American Indians and Alaska Natives: Results From the iCanQuit Trial,” (in eng), Nicotine Tob Res, vol. 24, no. 4, pp. 544-554, Mar 01 2022. [CrossRef]
- W. S. Choi et al., “All Nations Breath of Life: A Randomized Trial of Smoking Cessation for American Indians,” (in eng), Am J Prev Med, vol. 51, no. 5, pp. 743-751, Nov 2016. [CrossRef]
- L. R. Thomas, D. M. Donovan, R. L. Sigo, L. Austin, G. A. Marlatt, and S. Tribe, “The Community Pulling Together: A Tribal Community–University Partnership Project to Reduce Substance Abuse and Promote Good Health in a Reservation Tribal Community,” (in eng), J Ethn Subst Abuse, vol. 8, no. 3, pp. 283-300, 2009. [CrossRef]
- R. Idoate et al., “Urban American Indian Community Health Beliefs Associated with Addressing Cancer in the Northern Plains Region,” (in eng), J Cancer Educ, vol. 36, no. 5, pp. 996-1004, Oct 2021. [CrossRef]
- A. Dror et al., “Vaccine hesitancy: the next challenge in the fight against COVID-19,” (in eng), Eur J Epidemiol, vol. 35, no. 8, pp. 775-779, Aug 2020. [CrossRef]
- S. Zintel, C. S. Zintel, C. Flock, A. L. Arbogast, A. Forster, C. von Wagner, and M. Sieverding, “Gender differences in the intention to get vaccinated against COVID-19: a systematic review and meta-analysis,” (in eng), Z Gesundh Wiss, pp. 1-25, Jan 07 2022. [CrossRef]
- S. L. Klein and A. Pekosz, “Sex-based biology and the rational design of influenza vaccination strategies,” (in eng), J Infect Dis, vol. 209 Suppl 3, no. Suppl 3, pp. S114-9, Jul 15 2014. [CrossRef]
- T. Galbadage et al., “Systematic Review and Meta-Analysis of Sex-Specific COVID-19 Clinical Outcomes,” (in eng), Front Med (Lausanne), vol. 7, p. 348, 2020. [CrossRef]
- C. Vitale, M. Fini, I. Spoletini, M. Lainscak, P. Seferovic, and G. M. Rosano, “Under-representation of elderly and women in clinical trials,” (in eng), Int J Cardiol, vol. 232, pp. 216-221, Apr 01 2017. [CrossRef]
- E. Conis, “A mother’s responsibility: women, medicine, and the rise of contemporary vaccine skepticism in the United States,” (in eng), Bull Hist Med, vol. 87, no. 3, pp. 407-35, 2013. [CrossRef]
- T. A.-P. G. i. H. A. W. Group, “GENDER AND COVID-19 VACCINES Listening to women-focused organizations in Asia and the Pacific,” a. V. Gender-Based Violence Area of Responsibility, Ed., ed. UN Women, 2021, p. 16.
- B. Spires, A. Brewton, J. M. Maples, S. F. Ehrlich, and K. B. Fortner, “Vaccine Hesitancy in Women’s Health,” (in eng), Obstet Gynecol Clin North Am, vol. 50, no. 2, pp. 401-419, Jun 2023. [CrossRef]
- L. A. Kassi, A. K. Lawson, E. C. Feinberg, A. Swanson, S. Shah, and M. Pavone, “Vaccine hesitancy, distress, and medical mistrust in women considering or undergoing fertility treatment during the COVID-19 pandemic,” (in eng), J Assist Reprod Genet, vol. 39, no. 12, pp. 2767-2776, Dec 2022. [CrossRef]
- A. R. Collaborative. “2022 Midterm Voter Election Poll: Native American Voters.” African American Research Collaborative. https://2022electionpoll.us/wp-content/uploads/2022/11/7-Midterm-Survey-NativeAm-National-Crosstab.pdf (accessed.
- J. D. Allen et al., “Medical mistrust, discrimination, and COVID-19 vaccine behaviors among a national sample U.S. adults,” (in eng), SSM Popul Health, vol. 20, p. 101278, Dec 2022. [CrossRef]
- K. F. Foundation. “arge Majorities Now Say they Wear Masks Regularly and can Continue Social Distancing for at least Six Months if Needed, though Republicans Remain Less Likely to Take Such Precautions.” Kaiser Family Foundation. https://www.kff.org/coronavirus-covid-19/press-release/poll-large-majorities-now-say-they-wear-masks-regularly-and-can-continue-social-distancing-for-at-least-six-months-if-needed-though-republicans-remain-less-likely-to-take-such-precautions/ (accessed 2021).
- S. R. Neely, C. Eldredge, R. Ersing, and C. Remington, “Vaccine Hesitancy and Exposure to Misinformation: a Survey Analysis,” (in eng), J Gen Intern Med, vol. 37, no. 1, pp. 179-187, Jan 2022. [CrossRef]
- C. Group, “A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation,” (in eng), Lancet Infect Dis, vol. 20, no. 7, pp. 769-770, Jul 2020. [CrossRef]
- J. D. Hanson, K. Oziel, A. Harris, M. Sarche, M. O’Leary, and D. Buchwald, “Adaptations of an RCT during COVID: Case Study in one Rural American Indian Community,” (in eng), Collaborations (Coral Gables), vol. 5, no. 1, 2022. [CrossRef]
- H. B. Nguyen et al., “Knowledge, Attitudes, Practices, and Related Factors Towards COVID-19 Prevention Among Patients at University Medical Center Ho Chi Minh City, Vietnam,” (in eng), Risk Manag Healthc Policy, vol. 14, pp. 2119-2132, 2021. [CrossRef]
- E. H. Hassan et al., “Knowledge, attitudes, and practices toward COVID-19 prevention in Yemen: a community-based cross-sectional study,” (in eng), Front Public Health, vol. 11, p. 1178183, 2023. [CrossRef]
- L. Szapary, J. C. Avila, M. A. Monnig, A. W. Sokolovsky, G. DeCost, and J. S. Ahluwalia, “Adherence to COVID-19 Guidelines among Current, Former, and Never Smokers,” (in eng), Am J Health Behav, vol. 46, no. 4, pp. 442-455, Sep 01 2022. [CrossRef]
- J. B. Unger, S. Shakib, T. B. Cruz, B. R. Hoffman, B. H. Pitney, and L. A. Rohrbach, “Smoking behavior among urban and rural Native American adolescents in California,” (in eng), Am J Prev Med, vol. 25, no. 3, pp. 251-4, Oct 2003. [CrossRef]
- L. G. Brown, E. R. Hoover, C. E. Barrett, K. L. Vanden Esschert, S. A. Collier, and A. G. Garcia-Williams, “Handwashing and disinfection precautions taken by U.S. adults to prevent coronavirus disease 2019, Spring 2020,” (in eng), BMC Res Notes, vol. 13, no. 1, p. 550, Dec 04 2020. [CrossRef]
- J. Reusch et al., “Inability to work following COVID-19 vaccination-a relevant aspect for future booster vaccinations,” (in eng), Public Health, vol. 222, pp. 186-195, Sep 2023. [CrossRef]
- E. J. Tomayko et al., “Healthy Children, Strong Families 2: A randomized controlled trial of a healthy lifestyle intervention for American Indian families designed using community-based approaches,” (in eng), Clin Trials, vol. 14, no. 2, pp. 152-161, Apr 2017. [CrossRef]
- S. Sigvardsson, M. Bohman, and C. R. Cloninger, “Replication of the Stockholm Adoption Study of alcoholism. Confirmatory cross-fostering analysis,” (in eng), Arch Gen Psychiatry, vol. 53, no. 8, pp. 681-7, Aug 1996. [CrossRef]
- G. L. I.-T. E. Center, “American Indian/Alaska Native Health in Michigan, Minnesota,and Wisconsin 2021,” ed. Lac du Flambeau, WI: Great Lakes Inter-Tribal Council, Inc., 2021.
- B. M. Popkin et al., “Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships,” (in eng), Obes Rev, vol. 21, no. 11, p. e13128, Nov 2020. [CrossRef]
- J. Xie et al., “Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans,” (in eng), Diabetes Care, vol. 44, no. 1, pp. 188-93, Aug 25 2020. [CrossRef]
- T. D. Sequist, T. Cullen, K. Bernard, S. Shaykevich, E. J. Orav, and J. Z. Ayanian, “Trends in quality of care and barriers to improvement in the Indian Health Service,” (in eng), J Gen Intern Med, vol. 26, no. 5, pp. 480-6, May 2011. [CrossRef]
- K. J. Cromer, L. Wofford, and D. K. Wyant, “Barriers to Healthcare Access Facing American Indian and Alaska Natives in Rural America,” (in eng), J Community Health Nurs, vol. 36, no. 4, pp. 165-187, 2019. [CrossRef]



| Characteristic | Total N (%) |
|---|---|
| Gender | |
| Female | 183 (67%) |
| Male | 85 (31%) |
| Other (Transgender male, Gender Variant/Non-Conforming, Prefer not to say) |
5 (2%) |
| Age | |
| 18–24 years old | 39 (14%) |
| 25–34 years old | 60 (22%) |
| 35–44 years old | 57 (21%) |
| 45–54 years old | 45 (16%) |
| 55–64 years old | 44 (16%) |
| 65+ years old | 28 (10%) |
| Ethnicity | |
| Hispanic | 22 (9%) |
| Non-Hispanic | 224 (91%) |
| Residence | |
| Nonmetropolitan | 21 (8%) |
| Micropolitan | 216 (79%) |
| Metropolitan | 35 (13%) |
| Political affiliation | |
| Republican | 40 (15%) |
| Democrat | 80 (30%) |
| Independent | 65 (24%) |
| Something else | 84 (31%) |
| Employment status | |
| Affected by COVID-19 pandemic | 128 (55%) |
| Not affected by COVID-19 pandemic | 106 (45%) |
| Essential worker during pandemic | |
| Self and/or household member | 86 (32%) |
| Someone in household | 53 (19%) |
| No one in household is an essential worker | 134 (49%) |
| Tested self for COVID-19 during pandemic | |
| Yes | 242 (88%) |
| No/Not sure | 34 (12%) |
| History of testing positive for COVID-19 | |
| Yes | 246 (90%) |
| No/Not sure | 27 (10%) |
| Hospitalized for COVID-19 | |
| Yes | 158 (58%) |
| No/Not sure | 115 (42%) |
| Number of co-morbidities (self) | |
| None | 56 (21%) |
| One co-morbidity | 127 47%) |
| Two or more co-morbidity | 90 (33%) |
| Number of co-morbidities (household, other than self) | |
| None | 65 (24%) |
| One co-morbidity | 110 (40%) |
| Two or more co-morbidity | 98 (36%) |
| # of CDC precautions followed | |
| Zero/One | 31 (11%) |
| Two/Three | 42 (15%) |
| Four/Five | 69 (25%) |
| Six/Seven | 59 (22%) |
| Eight/Nine | 35 (13%) |
| Ten/Eleven | 37 (14%) |
| Received flu shot last season | |
| Yes | 154 (58%) |
| No | 112 (42%) |
| Have or will receive flu shot this year | |
| Yes | 142 (52%) |
| No | 90 (33%) |
| Undecided | 41 (15%) |
| COVID-19 vaccination likelihood | |
| Definitely will not, Very unlikely, Somewhat unlikely | 84 (31%) |
| Somewhat likely, Very likely, Definitely will | 27 (10%) |
| Already partially or completely vaccinated | 162 (59%) |
| Knowledge topics | Before intervention (x̄) 11 | After intervention (x̄)1 | Mean difference (∆x̄) | Standard deviation | t* | p-value |
|---|---|---|---|---|---|---|
| Measures to protect against COVID-19 transmission | 1.11 | 1.39 | 0.28 | 0.77 | 6.05 | <0.001 |
| Modes of COVID-19 spread | 1.42 | 1.42 | 0.00 | 0.80 | 0.08 | 0.94 |
| Vaccine effects | 1.41 | 1.55 | 0.14 | 0.87 | 2.65 | 0.008 |
| COVID-19 vaccine efficacy | 1.41 | 1.6 | 0.19 | 0.83 | 3.74 | <0.001 |
| Post-vaccine behavior | 1.36 | 1.48 | 0.13 | 0.83 | 2.49 | 0.013 |
| COVID-19 side effects | 1.33 | 1.4 | 0.07 | 0.82 | 1.49 | 0.138 |
| COVID-19 vaccine development | 0.75 | 0.95 | 0.19 | 0.89 | 3.61 | <0.001 |
| Gender | Political affiliation | Employment status | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knowledge topics | Female (∆x̄) | Male (∆x̄) | t | p-value | Republican (∆x̄) | Democrat (∆x̄) | Independent (∆x̄) | Something else (∆x̄) | F | p-value | Unaffected (∆x̄) | Affected (∆x̄) | t | p-value |
|
Measures to protect against COVID-19 transmission |
0.27 | 0.29 | -0.14 | 0.888 | 0.23 | 0.20 | 0.29 | 0.37 | 0.73 | 0.536 | 0.31 | 0.26 | 0.82 | 0.599 |
| Vaccine effects | 0.19 | 0.03 | 1.34 | 0.183 | 0.05 | 0.11 | 0.12 | 0.20 | 0.32 | 0.813 | 0.05 | 0.25 | 0.86 | 0.075 |
|
COVID-19 vaccine efficacy |
0.22 | 0.10 | 1.08 | 0.283 | 0.53 | 0.06 | 0.12 | 0.18 | 3.05 | 0.029 | 0.08 | 0.30 | 0.91 | 0.043 |
| Post-vaccine behavior | 0.21 | -0.06 | 2.48 | 0.014 | 0.03 | 0.10 | 0.31 | 0.06 | 1.51 | 0.213 | 0.08 | 0.19 | 0.90 | 0.353 |
| COVID-19 vaccine development | 0.20 | 0.17 | 0.21 | 0.834 | 0.03 | 0.00 | 0.25 | 0.40 | 3.50 | 0.016 | 0.18 | 0.21 | 0.94 | 0.786 |
| Attitude topics | Before intervention (x̄)2 | After intervention (x̄)2 | Mean difference (∆x̄) | Standard deviation | t* | p-value |
|---|---|---|---|---|---|---|
| Trust in COVID-19 vaccine effectiveness and safety | 1.12 | 1.28 | 0.17 | 0.77 | 3.46 | <0.001 |
| Personal belief in the benefits of COVID-19 vaccination | 1.29 | 1.37 | 0.09 | 0.55 | 2.517 | 0.012 |
| Confidence in COVID-19 vaccine testing and results | 1.26 | 1.36 | 0.10 | 0.61 | 2.539 | 0.012 |
| Perception of rapid COVID-19 vaccine development | 1.09 | 0.98 | -0.10 | 0.69 | -2.418 | 0.016 |
| Concerns about COVID-19 vaccine side effects | 1.11 | 0.98 | -0.13 | 0.81 | -2.591 | 0.01 |
| Concerns about long-term effects of COVID-19 vaccines | 1.22 | 1.06 | -0.16 | 0.74 | -3.453 | <0.001 |
| Challenges in discerning trustworthy vaccine information | 1.13 | 1.04 | -0.10 | 0.82 | -1.911 | 0.057 |
| Influence of trusted sources on vaccination | 1.31 | 1.45 | 0.13 | 0.76 | 2.794 | 0.006 |
| Concerns about missing work due to vaccine side effects | 0.59 | 0.51 | -0.09 | 0.71 | -1.955 | 0.052 |
| Gender | Residence | COVID-19 tested | Risk co-morbidities (self) | CDC | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attitude topics | Female (∆x̄) | Male (∆x̄) | t | p-value | Nonmetropolitan (∆x̄) | Micropolitan (∆x̄) | Metropolitan (∆x̄) | F | p-value | No/Don’t know (∆x̄) | Yes (x̄) | t | p-value | None (∆x̄) | One (∆x̄) | Two or more (∆x̄) | F | p-value | Precautions (r) | p-value |
| Trust in COVID-19 vaccine effectiveness and safety | 0.19 | 0.10 | 0.95 | 0.342 | 0.16 | 0.18 | 0.03 | 0.56 | 0.571 | 0.35 | 0.14 | 1.46 | 0.145 | 0.06 | 0.17 | 0.22 | 0.75 | 0.473 | 0.05 | 0.42 |
| Personal belief in the benefits of COVID-19 vaccination | 0.09 | 0.07 | 0.21 | 0.838 | 0.11 | 0.07 | 0.12 | 0.12 | 0.884 | 0.21 | 0.07 | 1.27 | 0.204 | 0.23 | 0.09 | -0.01 | 3.25 | 0.04 | -0.02 | 0.78 |
| Confidence in COVID-19 vaccine testing and results | 0.10 | 0.08 | 0.17 | 0.865 | 0.06 | 0.09 | 0.12 | 0.06 | 0.941 | -0.06 | 0.12 | -1.57 | 0.118 | 0.08 | 0.10 | 0.11 | 0.04 | 0.963 | -0.05 | 0.45 |
| Perception of rapid COVID-19 vaccine development | -0.11 | -0.07 | -0.46 | 0.646 | -0.11 | -0.09 | -0.19 | 0.29 | 0.748 | -0.25 | -0.08 | -1.27 | 0.205 | -0.10 | 0.02 | -0.28 | 4.70 | 0.01 | -0.07 | 0.25 |
| Concerns about COVID-19 vaccine side effects | -0.05 | -0.30 | 2.31 | 0.021 | -0.32 | -0.06 | -0.47 | 4.37 | 0.014 | -0.25 | -0.11 | -0.89 | 0.377 | -0.25 | -0.01 | -0.24 | 2.69 | 0.07 | 0.11 | 0.09 |
| Concerns about long-term effects of COVID-19 vaccines | -0.09 | -0.32 | 2.32 | 0.021 | -0.28 | -0.11 | -0.41 | 2.70 | 0.069 | -0.42 | -0.12 | -2.09 | 0.038 | -0.10 | -0.03 | -0.39 | 6.17 | 0.002 | 0.01 | 0.88 |
| Influence of trusted sources on vaccination | 0.15 | 0.11 | 0.35 | 0.724 | 0.37 | 0.11 | 0.16 | 1.02 | 0.361 | 0.13 | 0.13 | -0.03 | 0.973 | 0.10 | 0.16 | 0.12 | 0.15 | 0.864 | -0.02 | 0.72 |
| Concerns about missing work due to vaccine side effects | -0.09 | -0.07 | -0.20 | 0.839 | 0.05 | -0.11 | -0.03 | 0.55 | 0.576 | -0.06 | -0.09 | 0.21 | 0.837 | -0.10 | -0.04 | -0.14 | 0.53 | 0.591 | 0.15 | 0.02 |
| Vaccine status | |||||
|---|---|---|---|---|---|
| Unvaccinated, hesitated 3 (∆x̄, N=84) |
Unvaccinated, not hesitant 4 (∆x̄, N=27) |
Vaccinated (∆x̄, N=162) |
F | p-value | |
| Knowledge topics | |||||
| Measures to protect against COVID-19 transmission | 0.43 | 0.11 | 0.26 | 2.17 | 0.116 |
| Vaccine effects | 0.39 | -0.11 | 0.04 | 5.75 | 0.004 |
| COVID-19 vaccine efficacy | 0.49 | 0.11 | 0.02 | 9.25 | <.001 |
| Post-vaccine behavior | 0.25 | 0.04 | 0.08 | 1.35 | 0.261 |
| COVID-19 vaccine development | 0.27 | 0.44 | 0.11 | 2.10 | 0.125 |
| Attitude topics | |||||
| Trust in COVID-19 vaccine effectiveness and safety | 0.16 | 0.08 | 0.19 | 0.20 | 0.821 |
| Personal belief in the benefits of COVID-19 vaccination | 0.21 | 0.21 | -0.01 | 4.59 | 0.011 |
| Confidence in COVID-19 vaccine testing and results | 0.03 | 0.08 | 0.14 | 0.82 | 0.442 |
| Perception of rapid COVID-19 vaccine development | -0.01 | -0.12 | -0.18 | 1.50 | 0.226 |
| Concerns about COVID-19 vaccine side effects | -0.10 | 0.17 | -0.15 | 1.61 | 0.203 |
| Concerns about long-term effects of COVID-19 vaccines | -0.04 | -0.29 | -0.17 | 1.42 | 0.244 |
| Influence of trusted sources on vaccination | 0.23 | -0.08 | 0.13 | 1.61 | 0.203 |
| Concerns about missing work due to vaccine side effects | -0.10 | -0.24 | -0.05 | 0.78 | 0.462 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).